Market Overview

Milberg LLP Announces Pendency of Class Action Lawsuits Filed Against Peregrine Pharmaceuticals

Related PPHM
Earnings Scheduled For July 14, 2014
Medivation Signs Deal with OncoFusion Therapeutics - Analyst Blog

Milberg LLP announces that class action lawsuits were filed in the United States District Court for the Central District of California on behalf of purchasers of Peregrine Pharmaceuticals, Inc. (“Peregrine”) (NASDAQ: PPHM) common stock during the period July 16, 2012 to September 26, 2012, (the “Class Period”).

Milberg LLP has created a website (http://www.PeregrineLawsuit.com) that seeks to answer common questions about shareholder class actions.

Posted-In: News FDA

 

Related Articles (PPHM)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters